EICHORCondition: Post Operative Surgical Site Infection · Sponsor: Major Extremity Trauma Research Consortium
The overall objective is to compare the effect of Vancomycin and Tobramycin powder combined (treatment) to Vancomycin powder (control) in the reduction of post-fixation infections of tibial plateau and tibial pilon fractures at high risk of infection (collectively considered the "study injuries").
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama Heersink School of Medicine | Birmingham, Alabama, United States | — |
| Keck School of Medicine of USC | Los Angeles, California, United States | — |
| Stanford University | Redwood City, California, United States | — |
| _University of California, San Francisco | San Francisco, California, United States | — |
| Cedars Sinai | West Hollywood, California, United States | — |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | — |
| St Mary's University/Tenent Health | West Palm Beach, Florida, United States | — |
| Loyola University Chicago | Chicago, Illinois, United States | — |
| Indiana University School of Medicine - Methodist Hospital | Indianapolis, Indiana, United States | — |
| Indiana University/Eskenazi Health | Indianapolis, Indiana, United States | — |
| University of Kentucky | Lexington, Kentucky, United States | — |
| LSU Health Sciences | New Orleans, Louisiana, United States | — |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04597008